Search Results - "Teruo Shiba"

Chronic cold agglutinin disease after a third COVID-19 mRNA vaccination by Suzuki, Yutaro, Shiba, Teruo

“…COVID-19 mRNA vaccines manufactured by Pfizer-BioNTech and Moderna have been approved in many countries, and have been administered since 2020. Recent reports…”
Get full text

Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody—insight into the pathogenesis of autoimmune endocrinopathy by Okahata, Sumie, Sakamoto, Kentaro, Mitsumatsu, Takako, Kondo, Yuko, Noso, Shinsuke, Ikegami, Hiroshi, Shiba, Teruo

“…Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer therapy, but…”
Get full text

Pancreatic Inflammation Captured by Imaging Technology at the Onset of Fulminant Type 1 Diabetes by Obata, Atsushi, Kaneto, Hideaki, Kamei, Shinji, Shimoda, Masashi, Kishi, Satoru, Isogawa, Akihiro, Shiba, Teruo

Get full text

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins by Sakamoto, Kentaro, Kawamura, Mitsunobu, Kohro, Takahide, Omura, Masao, Watanabe, Takayuki, Ashidate, Keiko, Horiuchi, Toshiyuki, Hara, Hidehiko, Sekine, Nobuo, Chin, Rina, Tsujino, Motoyoshi, Hiyoshi, Toru, Tagami, Motoki, Tanaka, Akira, Mori, Yasumichi, Inazawa, Takeshi, Hirano, Tsutomu, Yamazaki, Tsutomu, Shiba, Teruo

“…There exists a subpopulation of T2DM in whom first-line doses of statin are insufficient for optimally reducing LDL-C, representing a major risk of CVD. The…”
Get full text

Guidelines for Elective Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (JCS 2011) Published in 2012: Digest Version by Group, JCS Joint Working

Get full text

Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects by Sakamoto, Kentaro, Kawamura, Mitsunobu, Watanabe, Takayuki, Ashidate, Keiko, Kohro, Takahide, Tanaka, Akira, Mori, Yasumichi, Tagami, Motoki, Hirano, Tsutomu, Yamazaki, Tsutomu, Shiba, Teruo

“…Lowering cholesterol levels decreases the risk of atherosclerotic diseases. Effective ways to stably reduce LDL-C level are warranted in type 2 diabetic…”
Get full text

Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody - insight into the pathogenesis of autoimmune endocrinopathy by Sumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, Yuko Kondo, Shinsuke Noso, Hiroshi Ikegami, Teruo Shiba

“…Abstract. Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer…”
Get full text

Discrete effects of glimepiride and metformin on preprandial and postprandial glucose and contributions to the amelioration of chronic hyperglycemia by Sakamoto, Kentaro, Shiba, Teruo

“…Glimepiride and metformin have been adopted throughout the world as effective regulators of fasting glucose. Little is known, however, about the effects of…”
Get full text

Improvement of insulin resistance by a new insulin secretagogue, nateglinide—analysis based on the homeostasis model by Shiba, Teruo

“…Type 2 diabetes is a heterogeneous disorder characterized by defects in the early phase of insulin secretion after meals and in insulin resistance at its early…”
Get full text

Guidelines for the Clinical Application of Bypass Grafts and the Surgical Techniques (JCS 2011) Published in 2012: Digest Version by Group, JCS Joint Working

Get full text

Cardiac Amyloidosis Presumptively Diagnosed as Cardiac Syndrome X by Yagishita, Atsuhiko, Tanimoto, Shuzou, Tanabe, Kengo, Isogawa, Akihiro, Taniguchi, Makoto, Shiba, Teruo, Hara, Kazuhiro

“…A 75-year-old man with cardiac amyloidosis was presumptively diagnosed as having cardiac syndrome X. Early clinical presentation was repeated episodes of…”
Get full text

Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance (the J-PREDICT study): rationale, study design, and clinical characteristics of 1269 patients by Yamazaki, Tsutomu, Kishimoto, Junji, Ito, Chikako, Noda, Mitsuhiko, Odawara, Masato, Terauchi, Yasuo, Shiba, Teruo, Kitazato, Hiroji, Iwamoto, Yasuhiko, Akanuma, Yasuo, Kadowaki, Takashi

“…Objective The Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance (J-PREDICT study) is an open-label randomized…”
Get full text

Biochemical and molecular mechanisms in the development of diabetic vascular complications by KING, G. L, KUNISAKI, M, NISHIO, Y, INOGUCHI, T, SHIBA, T, XIA, P

“…Hyperglycemia is the major causal factor in the development of diabetic vascular complications. The mechanism by which hyperglycemia causes the complications…”
Get full text

Knowledge and Demand for Information about Islet Transplantation in Patients with Type 1 Diabetes by Kazuma, Keiko, Mori, Yasumichi, Shiba, Teruo, Kobayashi, Tetsuro, Hayashi, Michio, Kato, Naoko, Yamamoto, Yuko, Nishigaki, Masakazu

“…This cross-sectional study based on self-administrated questionnaire was conducted to investigate knowledge, related factors, and sources of information…”
Get full text

CELLULAR AND MOLECULAR ABNORMALITIES IN THE VASCULAR ENDOTHELIUM OF DIABETES MELLITUS by King, George L, Shiba, Teruo, Oliver, Javier, Inoguchi, Toyoshi, Bursell, Sven-Erik

“…Diabetic vascular complications affect both micro- and macrovasculature, primarily in the retina, renal glomeruli, and multiple sites in the macrovessels. This…”
Get full text

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial by Ueki, Kohjiro, Sasako, Takayoshi, Okazaki, Yukiko, Kato, Masayuki, Okahata, Sumie, Katsuyama, Hisayuki, Haraguchi, Mikiko, Morita, Ai, Ohashi, Yasuo, Kadowaki, Takashi, Haneda, Masakazu, Iwashima, Yasunori, Suda, Toshihiro, Satoh, Jo, Takebe, Noriko, Watanabe, Tsuyoshi, Kasai, Kikuo, Ishibashi, Shun, Katayama, Shigehiro, Ishikawa, San-e, Kakei, Masafumi, Namai, Kazuyuki, Suzuki, Yoshifumi, Yokote, Koutaro, Hayashi, Yoichi, Saito, Satoshi, Ogihara, Norikazu, Ishihara, Hisamitsu, Shimada, Akira, Itoh, Hiroshi, Watada, Hirotaka, Mori, Yasumichi, Shiba, Teruo, Isogawa, Akihiro, Hirata, Yukio, Uchimura, Isao, Yoshino, Gen, Hirose, Takahisa, Atsumi, Yoshihito, Oikawa, Yoichi, Ueki, Akio, Ohno, Atsushi, Kitaoka, Masafumi, Fujita, Yoshikuni, Moriya, Tatsumi, Tojo, Taiki, Shichiri, Masayoshi, Suzuki, Daisuke, Hamano, Kumiko, Kuzuya, Nobuaki, Takamura, Toshinari, Tanaka, Hiroshi, Hayashi, Masayuki, Kato, Yasuhisa, Itoh, Mitsuyasu, Nakayama, Mikihiro, Sano, Takahisa, Sumida, Yasuhiro, Tanaka, Tsuyoshi, Kashiwagi, Atsunori, Kono, Shigeo, Yasuda, Tetsuyuki, Yoshimasa, Yasunao, Kishimoto, Ichiro, Sato, Toshihiko, Matsuhisa, Munehide, Shimomura, Iichiro, Kuroe, Akira, Kurose, Takeshi, Ohara, Takeshi, Sakaguchi, Kazuhiko, Namba, Mitsuyoshi, Kaku, Kohei, Fujiwara, Masazumi, Ebisui, Osamu, Tanizawa, Yukio, Kodera, Takehiko, Sato, Naoichi, Ide, Makoto, Yamada, Kentaro, Eto, Tomoaki, Mimura, Kazuo, Hiramatsu, Shinsuke, Inoue, Tomoaki, Takei, Ryoko, Ogo, Atsushi, Kawasaki, Eiji, Araki, Eiichi, Yamamoto, Hiroaki, Hiyoshi, Toru, Sato, Koichiro, Yoneyama, Akihiko, Ito, Kenichi, Sobajima, Hiroshi, Ikeda, Masaki, Ikeda, Hiroki, Takahashi, Kenji, Makino, Hirofumi, Ueda, Yasuo, Nakazato, Masamitsu

“…Limited evidence suggests that multifactorial interventions for control of glucose, blood pressure, and lipids reduce macrovascular complications and mortality…”
Get full text

Effect of GLP-1 receptor agonists on free fatty acids and implication for preventing atherosclerosis by Sakamoto, Kentaro, Okahata, Sumie, Mitsumatsu, Takako, Shiba, Teruo

Get full text

Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease by Moroi, Masao, Nagayama, Daiji, Hara, Fumihiko, Saiki, Atsuhito, Shimizu, Kazuhiro, Takahashi, Mao, Sato, Naoko, Shiba, Teruo, Sugimoto, Hideki, Fujioka, Toshiki, Chiba, Tatsuo, Nishizawa, Kosuke, Usui, Shuki, Iwasaki, Yasuo, Tatsuno, Ichiro, Sugi, Kaoru, Yamasaki, Junichi, Yamamura, Shigeo, Shirai, Kohji

“…There has been no report about outcome of pitavastatin versus atorvastatin therapy in high-risk patients with hypercholesterolemia. Hypercholesterolemic…”
Get full text

Mechanistic insights from sequential combination therapy with a sodium glucose co‐transporter‐2 inhibitor and a dipeptidyl peptidase‐4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptin by Okahata, Sumie, Sakamoto, Kentaro, Mitsumatsu, Takako, Kondo, Yuko, Tanaka, Shoji, Shiba, Teruo

“…Aim To elucidate the mechanisms involved in the sequential use of SGLT2 and DPP4 inhibitors (SGLT2i and DPP‐4i). Methods Twenty‐six type‐2 diabetes mellitus…”
Get full text

Effect of Ezetimibe Add-On Therapy on Non-HDL-C in Type 2 Diabetes Subjects—A Post-Hoc Analysis of RESEARCH Study by SAKAMOTO, KENTARO, KAWAMURA, MITSUNOBU, TAGAMI, MOTOKI, TANAKA, AKIRA, MORI, YASUMICHI, HIRANO, TSUTOMU, SHIBA, TERUO

“…Background: In RESEARCH study, we demonstrated the superiority of ezetimibe add-on therapy over statin-doubling in T2DM.Non-HDL-C is attracting attention as an…”
Get full text